Premium
Patient outcome after implant of a cardioverter defibrillator in the ‘real world’: the key role of co‐morbidities
Author(s) -
Boriani Giuseppe,
Malavasi Vincenzo Livio
Publication year - 2017
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.743
Subject(s) - medicine , implantable cardioverter defibrillator , heart failure , clinical trial , cardiac resynchronization therapy , myocardial infarction , sudden cardiac death , randomized controlled trial , canadian cardiovascular society , intensive care medicine , cardiology , ejection fraction , angina
This article refers to 'The impact of co-morbidity burden on appropriate implantable cardioverter defibrillator therapy and all-cause mortality: insight from Danish nationwide clinical registers,' by A.C. Ruwald et al., published in this issue on pages 377-386